SlideShare a Scribd company logo
1 of 52
Introduction to         MedDRA®
  and its use
Kathryn Huntley
Huntley Consulting, LLC
DAIDS Contractor
February 21, 2006

                                    1
MedDRA

Med= Medical
D = Dictionary for
R = Regulatory
A = Activities


                     2
MedDRA Definition
MedDRA is a clinically-validated
international medical terminology used by
regulatory authorities and the regulated
biopharmaceutical industry. The terminology
is used through the entire regulatory process,
from pre-marketing to post-marketing and for
data entry, retrieval, evaluation and
presentation
                                                 3
Scope
                                        OUT
    Drug product terms
                                         IN
                                       Diseases             Population-level qualifiers
                                      Diagnoses
                                         Signs
                                      Symptoms
Patient demographic            Therapeutic indications           Numerical values for
        terms             Investigation names & qualitative              results
                                        results
                           Medical & surgical procedures
                            Medical, social, family history
                                    Terms from:
                                      COSTART
  Device failure terms                WHO-ART                   Severity descriptors
                                       HARTS
                                                         Equipment, device,
                                                         diagnostic product terms
   Clinical trial study design terms
MedDRA Structure and Growth
Version 2.1   Version 7.0   Version 8.0
      26            26            26       System Organ Class



     334           332           332      High-Level Group Term




   1,663         1,681         1,683         High-Level Term




  11,193        16,449        16,751         Preferred Term




  35,065        44,755        45,597         Lowest-Level Term



                                                               5
MedDRA Structure and Growth
     Version 8.0   Version 8.1
           26            26       System Organ Class



          332           332      High-Level Group Term




        1,683         1,683        High-Level Term




       16,751        16,976         Preferred Term




       45,597        45,974         Lowest-Level Term



                                                     6
System Organ Class
   Highest level of the hierarchy
   SOCs identified by
     Anatomical or physiological system
     Etiology
     Purpose




                                          7
System Organ Class
Blood and lymphatic system           Musculoskeletal and connective
disorders                            tissue disorders
Cardiac disorders                    Neoplasms benign, malignant and
Congenital, familial and genetic     unspecified (incl cysts and polyps)
disorders                            Nervous system disorders
Ear and labyrinth disorders          Pregnancy, puerperium and
Endocrine disorders                  perinatal conditions
Eye disorders                        Psychiatric disorders
Gastrointestinal disorders           Renal and urinary disorders
General disorders and                Reproductive system and breast
administration site conditions       disorders
Hepatobiliary disorders              Respiratory, thoracic and
Infections and infestations          mediastinal disorders
Immune system disorders              Skin and subcutaneous tissue
                                     disorders
Injury, poisoning and procedural     Social circumstances
complications
Investigations                       Surgical and medical procedures
Metabolism and nutrition disorders   Vascular disorders

                                                                           8
High Level Group Term
 Subordinate only to System Organ
 Classes and superordinate descriptor for
 one or more HLTs
                          SOC
                Gastrointestinal disorders




     HLGT                   HLGT                 HLGT
   Dental and          Gastrointestinal      Gastrointest
    gingival             infections          inal vascular
   conditions                                 conditions
High Level Term
 Subordinate to HLGTs and superordinate
 descriptors for the PTs linked to it
                         SOC
                    Gastrointestinal
                      disorders


                          HLGT
                Gastrointestinal infections



                           HLT
      HLT
                     Gastrointestinal                 HLT
   Intestinal
                     infections, site         Peritoneal infections
  infections
                       unspecified
Preferred Term
 Each Preferred Term represents a single
 medical concept:

   •   SOC Gastrointestinal disorders – HLGT Gastrointestinal
       infections – HLT - Gastrointestinal infections, site unspecified
       - PTs Abdominal sepsis, Amoebic dysentery, Tuberculosis
        gastrointestinal, Gastrointestinal anthrax . . .




                                                                     11
Preferred Term
 PT Characteristics
    •   No limit to the amount of LLTs that can be
        associated with a single PT
    •   An identical LLT is created for every PT
    •   Each path to a SOC from a PT should have exactly
        one HLT and HLGT (one route)
                PT → HLT → HLGT → SOC
    •   PTs can be represented in multiple SOCs
        (multiaxality)

                                                       12
Lowest Level Term
 LLT Characteristics: Developed to
   support consistent coding
   •   An LLT has one or more of the following
       relationships to a PT:
        – Synonym
        – Lexical variant
        – Quasi-synonym (colloquial terms)
   •   Many terms from included terminologies
       are represented at the LLT level
                                                 13
Lowest Level Term
 LLT Characteristics cont.
   •   Constitutes the entry level of the
       terminology and is linked to a single PT
   •   Can have current or non-current status
   •   Culturally unique terms are found at this
       level



                                                   14
NEC = Not Elsewhere Classified
      For specific, yet miscellaneous, terms that do not readily fit into
      hierarchical classifications, used only at the HLT and HLGT
      levels


                                 HLT
                       Congenital disorders NEC


                                                                    PT
    PT                                                           Hereditary
Congenital        PT                PT                PT
                                                                angioedema
abnormality    Conjoined        Hereditary        Umbilical
                 twins          disorders        malformation
MedDRA Codes
  Each MedDRA term assigned an 8-digit numeric code
  The code is non-expressive
  Codes can fulfill a data field in various electronic
  submission types (e.g., E2b)
  Initially assigned alphabetically by term starting with
  10000001
     New terms are assigned sequentially
  Codes are never reused
  Supplemental terms are assigned codes

                                                        16
Anatomy (Body System)
 Blood and lymphatic system disorders
 Cardiac disorders
 Ear and labyrinth disorders
 Endocrine disorders
 Eye disorders
 Gastrointestinal disorders
 Hepatobiliary disorders
 Immune system disorders
 Musculoskeletal and connective tissue disorders
 Nervous system disorders
 Psychiatric disorders
 Renal and urinary disorders
 Reproductive system and breast disorders
 Respiratory, thoracic and mediastinal disorders
 Skin and subcutaneous tissue disorders
 Vascular disorders
                                                   17
Other (Cause/Association)
 Congenital, familial and genetic disorders
 General disorders and administration site conditions
 Infections and infestations
 Injury, poisoning and procedural complications
 Investigations
 Metabolism and nutrition disorders
 Neoplasms benign, malignant and unspecified (incl cysts and polyps)
 Pregnancy, puerperium and perinatal conditions
 Social circumstances
 Surgical and medical procedures




                                                                       18
General disorders and administration site
conditions
  SOC specific topics:
      SOC includes terms that are very general in nature
      e.g.. Pain, Mass, Tenderness etc.
      Administration site conditions all grouped here
      (also in Injury SOC).
       • Application
       • Injection
       • Implant
      Much of this SOC is not multi-axial



                                                      19
Congenital, familial and genetic
disorders
  SOC specific topics:
  Primary SOC for all congenital conditions
    Primary SOC for all congenital conditions
      Congenital = any condition present at birth,
      whether genetically inherited or acquired in utero
      definition used for placement into this SOC
      HLGTs categorized either by an anatomical basis
      following the naming conventions of the SOCs
      Look here for the congenital condition, look in the
      anatomy SOC for grouping with non-congenital
      conditions

                                                        20
Injury, poisoning and procedural
complications
  SOC specific topics:
      Can be considered the “due to SOC”
      HLGTs are representing either the agent
      that caused the injury or anatomy
      Only SOC where cardiac and vascular are
      considered together (cardiovascular
      injuries)
      Overdose, poisoning, misadministrations
      etc are located here

                                                21
Investigations
 SOC specific topics:
      Single axial SOC
      Represents only the results of tests (no
      interpretation)
      HLGTs represent various large groupings of tests
      PTs naming convention is: Test identifier,
      specimen type, qualifier
       • Qualifiers include: normal, increased,
         decreased, abnormal NOS (no direction of
         abnormality specified)
         – There will always be an investigation term
         without any qualifier to be used when no value
         is given (e.g., PT: Hematocrit)
                                                          22
Infections and infestations

  SOC specific topics:
      All infections are primary to the Infection SOC
      HLGTs categorized either infectious agent or on an
      anatomical basis under pathogen class unknown.
      HLGT refers to taxonomy of pathogen e.g..
      Bacterial, Fungal etc.
      HLT references the genus
      PT refers to genus plus anatomy
      LLT references the species



                                                      23
Metabolism and nutrition disorders

  SOC specific topics:
      HLGTs represent metabolic disorders
      divided by substance being metabolized or
      nutritional disorders
      This SOC is based upon substance, cause
      would be represented in anatomical or
      congenital SOCs




                                              24
Neoplasms benign, malignant and
unspecified (incl cysts and polyps)
    SOC specific topics:
      Primary SOC for all Neoplasms
      Secondary SOC for all Cysts and Polyps
      Developed with the help of National Cancer
      Institute (CTEP)
      Applies international naming conventions
      HLGTs classify anatomy
      HLTs distinguish staging
      Includes very specific as well as very general
      terms

                                                       25
Pregnancy, puerperium and perinatal
conditions
    SOC specific topics:
      Contains terms for classifying disorders as well as
      normal conditions
      Age is important in using this SOC e.g.. Neonatal
      Topics of mother and child are covered within this
      SOC
      The HLGT Abortion and stillbirth includes
      spontaneous and abnormal conditions, procedures
      and complications


                                                        26
Social circumstances
    SOC specific topics:
      Contains terms for categorizing life style factors
      Does not contain disorders
      Single axial
      Drug and chemical abuse does not include alcohol
      Coding with this SOC requires full understanding
      of the SOC and its interpretation




                                                       27
Surgical and Medical Procedures
    SOC specific topics:
      HLGTs are broken down by anatomy or procedural
      type
      Only section of the terminology where Ear, nose
      and throat are grouped.
      Single axial
      Represents only procedures, complications are
      represented in the Injury, poisoning and
      procedural complications SOC, the reason for the
      procedure is represented in the disorders SOC

                                                    28
In what SOC would you find the
following:
   Hypoglycemia
   Decreased heart rate
   Drug addict
   Bacterial infection
   Pneumonitis
   Broken leg
   Injection site pain
                                 29
Using MedDRA’s Hierarchy
  Important functions of a hierarchy are as follows:
     Provides a grouping scheme for data analysis
     Defines the meaning of word and its relationship to terms
     associated with it
     Defines/limits the meaning of lateral terms
     Serves as a pre-developed method of grouping data for
     analysis
     Supports consistent data representation
     Supports standardized data reporting.
  MedDRA is NOT a taxonomy.
  Be careful to understand the interaction of the hierarchy and
  multiaxiality.
                                                                  30
A Multi-Axial Terminology
 Multi-axial = the representation of a
  medical concept in multiple SOCs
   Allows terms to be grouped by different
   classifications
   Allows retrieval and presentation via different data
   sets
   Allows an automatic assignment of pre-defined term
   groupings



                                                          31
Primary SOC Allocation
 Every PT is assigned to a Primary SOC
   Purpose of Primary SOC
   – Determines which SOC will represent a PT
     during cumulative data outputs
   – Is used to support consistent data
     presentation for reporting
   – Secondary SOCs are used for additional
     scientific analysis



                                                32
Rules for
Primary SOC Allocation
 PTs relating to diseases or signs and symptoms
   are assigned to the SOC that best represents
   the primary manifestation site
 PT: Appendicitis = Primary SOC:
            Gastrointestinal disorders
 PT: Dry Skin = Primary SOC:
      Skin & subcutaneous tissue disorders
 PT: Nausea = Primary SOC:
            Gastrointestinal disorders

                                              33
Exceptions for
Primary SOC Allocation
 All congenital and hereditary anomalies
   are placed in the Congenital, familial
   and genetic disorders SOC as their
   Primary SOC




                                            34
Exceptions for
Primary SOC Allocation
 Primary SOC Congenital and familial/genetic
 disorders
 Example PT
 Congenital rubella infection
 Secondary SOC
 Pregnancy, puerperium and perinatal conditions
 Infections and infestations


                                               35
Exceptions for
Primary SOC Allocation
 All neoplasms are placed in the
 Neoplasms benign and malignant
 (including cysts and polyps) SOC as their
 Primary SOC




                                             36
Exceptions for
Primary SOC Allocation
 Primary SOC Neoplasms benign,malignant and
   unspecified (including cysts and polyps)
 Example PT
 Benign lung neoplasm
 Secondary SOC
  Respiratory, thoracic
   and mediastinal disorders

                                          37
Exceptions for
Primary SOC Allocation
 Exception:

   Cysts and polyps are placed in the
      prime manifestation site as their
      Primary SOC




                                          38
Exceptions for
Primary SOC Allocation
Primary SOC Ear and labyrinth disorders
  Example PT             Secondary SOC
  Aural polyp             Neoplasms benign,
                            malignant and
                              unspecified
                         (including cysts and
                                polyps)


                                            39
Exceptions for
Primary SOC Allocation
 All infections and infestations are placed
   in the Infections and infestations SOC
   as their Primary SOC




                                              40
Exceptions for
Primary SOC Allocation
Primary SOC Infections and infestations
Example PTs                  Secondary SOC
Hepatitis C              Hepato-biliary disorders

                        Nervous system disorders
Encephalitis
                         Respiratory, thoracic and
Pneumonia                  mediastinal disorders

                                                41
A Multiaxial Terminology
  PTs in the following SOCs only appear
  in that particular SOC:
    Investigations
    Social circumstances
    Surgical and medical procedures.




                                          42
Multiaxial Terminology
   SOC = Respiratory, thoracic and                  SOC = Infections and
         mediastinal disorders                            infestations



    HLGT = Upper respiratory                        HLGT = Viral infectious
           tract infections                                disorders



    HLT =Viral upper respiratory                     HLT = Influenza viral
         tract infections                                  infections



                                   PT = Influenza

                                                                       43
A Multiaxial Terminology
       SOC = Endocrine               SOC = Metabolism and
            disorders                         nutrition disorders



              HLGT = Glucose metabolism disorders
                 (including diabetes mellitus)


                    HLT = Diabetes mellitus
                     (including subtypes)


                     PT = Diabetes mellitus



                                                                    44
Using MedDRA to Your Benefit
Multiaxiality
      SOC= Infection and                  SOC = Hepatobiliary
      infestations                            disorders


      HLGT = Viral                         HLGT = Hepatic
        disease                              disorders

                       HLT = Hepatic
                       viral infection


                       PT = Hepatitis C


                                                            45
Using MedDRA to Your Benefit
Multiaxiality (Continued)
                          SOC = Hepatobiliary
                              disorders


                           HLGT = Hepatic
                             disorders


       HLT = Hepatic                            HLT = Hepatic signs
       viral infection                              and symptoms


       PT = Hepatitis C                            PT = Hepatomegaly

                                                                46
Using MedDRA to Your Benefit
Multiaxiality (Continued)
   Impact of multiaxiality on analysis:
     PTs are represented in more than one
     SOC.
     Secondary path is used in SOC analysis.
     Use of multiaxiality.
     Double counting is prevented.
     Multiple data representation is supported.
     Related terms in different SOCs are
     revealed.                                    47
In what SOC would the following
terms be primary:
   Community acquired pneumonia
   Congenital HIV infection
   Kaposi’s Sarcoma
   HIV wasting syndrome
   Wasting
   Intestinal polyp
   Endometrial sarcoma
                                  48
Special Search Category
   Standardizes frequently used searches
   Helps define the syndromes/diseases
   Facilitates analysis across SOCs
   Groups PTs at the PT level
   (horizontally)
   Will be retired with MedDRA version 10


                                            49
Special Search Categories
   Anaphylaxis (SSC)
   Arrest (Cardiac) (SSC)
   Blood dyscrasias/bone marrow depression (SSC)
   Cardiac ischaemia (SSC)
   Haemorrhage           (SSC)
   Hypersensitivity reactions (SSC)
   Oedema (SSC)
   Pain (SSC)
   Premalignant lesions (SSC)
   Secondary immunocompromised state (SSC)
   Thrombosis (SSC)
   Upper GI bleeding/perforation (SSC)
   Vasculitis (SSC)                                50
Standardized MedDRA Query
  Standardizes frequently used searches
  Helps define the syndromes/diseases
  Facilitates analysis across SOCs
  Allows for broad and narrow searches
  (sensitivity vs. specificity)
  Is tested by MedDRA subscribers
  Is maintained by the MedDRA MSSO


                                          51
Acknowledgement
  MedDRA® is a registered trademark of the International
  Federation of Pharmaceutical Manufacturers & Associations
  (IFPMA)




                                                              52

More Related Content

What's hot

ICSR (individual case safety report)
ICSR (individual case safety report)ICSR (individual case safety report)
ICSR (individual case safety report)ClinosolIndia
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceDr. Ramesh Bhandari
 
Clinical trail protocol and development
Clinical trail protocol and developmentClinical trail protocol and development
Clinical trail protocol and developmentChintamBaladattaSai
 
Role of Biostatistics in Clinical Trials
Role of Biostatistics in Clinical TrialsRole of Biostatistics in Clinical Trials
Role of Biostatistics in Clinical TrialsClinosolIndia
 
Defined daily dose-DDD
Defined daily dose-DDDDefined daily dose-DDD
Defined daily dose-DDDMubasheeraMg
 
Pharmacovigilance Process Work Flow - Katalyst HLS
Pharmacovigilance Process Work Flow - Katalyst HLSPharmacovigilance Process Work Flow - Katalyst HLS
Pharmacovigilance Process Work Flow - Katalyst HLSKatalyst HLS
 
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSDrug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSKatalyst HLS
 
Protocol development
Protocol developmentProtocol development
Protocol developmentAlisha Bansal
 
Institutional review board/Independent ethics Committee
Institutional review board/Independent ethics CommitteeInstitutional review board/Independent ethics Committee
Institutional review board/Independent ethics CommitteeChintamBaladattaSai
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)Manish Rajput
 
Informed consent in Clinical Trials
Informed consent in Clinical TrialsInformed consent in Clinical Trials
Informed consent in Clinical TrialsKaushik Mukhopadhyay
 
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSAggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSKatalyst HLS
 
DCGI prescreening new drug applications
DCGI prescreening new drug applicationsDCGI prescreening new drug applications
DCGI prescreening new drug applicationsitsaruns
 
Investigator's Brochure
Investigator's BrochureInvestigator's Brochure
Investigator's BrochureRiyaz Gohil
 
Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Dr. Rohith K Nair
 

What's hot (20)

Turacoz - Clinical Study Report
Turacoz - Clinical Study ReportTuracoz - Clinical Study Report
Turacoz - Clinical Study Report
 
The introduction of an orange book
The introduction of an orange bookThe introduction of an orange book
The introduction of an orange book
 
ICSR (individual case safety report)
ICSR (individual case safety report)ICSR (individual case safety report)
ICSR (individual case safety report)
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for Pharmacovigilance
 
Clinical trail protocol and development
Clinical trail protocol and developmentClinical trail protocol and development
Clinical trail protocol and development
 
Role of Biostatistics in Clinical Trials
Role of Biostatistics in Clinical TrialsRole of Biostatistics in Clinical Trials
Role of Biostatistics in Clinical Trials
 
Defined daily dose-DDD
Defined daily dose-DDDDefined daily dose-DDD
Defined daily dose-DDD
 
Pharmacovigilance Process Work Flow - Katalyst HLS
Pharmacovigilance Process Work Flow - Katalyst HLSPharmacovigilance Process Work Flow - Katalyst HLS
Pharmacovigilance Process Work Flow - Katalyst HLS
 
Med dra Basics
Med dra  BasicsMed dra  Basics
Med dra Basics
 
CIOMS (1).pptx
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptx
 
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSDrug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
 
Protocol development
Protocol developmentProtocol development
Protocol development
 
Institutional review board/Independent ethics Committee
Institutional review board/Independent ethics CommitteeInstitutional review board/Independent ethics Committee
Institutional review board/Independent ethics Committee
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)
 
Code of Federal Regulations
Code of Federal RegulationsCode of Federal Regulations
Code of Federal Regulations
 
Informed consent in Clinical Trials
Informed consent in Clinical TrialsInformed consent in Clinical Trials
Informed consent in Clinical Trials
 
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSAggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
 
DCGI prescreening new drug applications
DCGI prescreening new drug applicationsDCGI prescreening new drug applications
DCGI prescreening new drug applications
 
Investigator's Brochure
Investigator's BrochureInvestigator's Brochure
Investigator's Brochure
 
Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)
 

Similar to Med dra basic-training

Who art & med dra
Who art & med draWho art & med dra
Who art & med draPlessan Joy
 
Who art & med dra
Who art & med draWho art & med dra
Who art & med draPlessan Joy
 
Statisticians Can\'t Analyze Text!
Statisticians Can\'t Analyze Text!Statisticians Can\'t Analyze Text!
Statisticians Can\'t Analyze Text!Rick Watts
 
Information Genetic Content (IGC): a comprehensive discovery platform for dis...
Information Genetic Content (IGC): a comprehensive discovery platform for dis...Information Genetic Content (IGC): a comprehensive discovery platform for dis...
Information Genetic Content (IGC): a comprehensive discovery platform for dis...Thermo Fisher Scientific
 
Searching PubMed
Searching PubMedSearching PubMed
Searching PubMedTTUHSC
 
SNOMED CT and other healthcare terminology standards: competition or cooperat...
SNOMED CT and other healthcare terminology standards: competition or cooperat...SNOMED CT and other healthcare terminology standards: competition or cooperat...
SNOMED CT and other healthcare terminology standards: competition or cooperat...THL
 
The Translational Medicine
The Translational MedicineThe Translational Medicine
The Translational MedicineJoanne Luciano
 
Toward Creating a gold Standard of Drug Indications from FDA Drug Labels
Toward Creating a gold Standard of Drug Indications from FDA Drug LabelsToward Creating a gold Standard of Drug Indications from FDA Drug Labels
Toward Creating a gold Standard of Drug Indications from FDA Drug LabelsThe Children's Hospital of Philadelphia
 
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010The Spittoon
 
Dr shridhar jia children and young people with arthritis.ppt
Dr shridhar jia children and young people with arthritis.pptDr shridhar jia children and young people with arthritis.ppt
Dr shridhar jia children and young people with arthritis.pptmilanb1
 
Dr shridhar jia children and young people with arthritis.ppt 121011
Dr shridhar jia children and young people with arthritis.ppt 121011Dr shridhar jia children and young people with arthritis.ppt 121011
Dr shridhar jia children and young people with arthritis.ppt 121011milanb1
 
Dr shridhar jia children and young people with arthritis.ppt 121011
Dr shridhar jia children and young people with arthritis.ppt 121011Dr shridhar jia children and young people with arthritis.ppt 121011
Dr shridhar jia children and young people with arthritis.ppt 121011milanb1
 
Dr shridhar jia children and young people with arthritis
Dr shridhar jia children and young people with arthritisDr shridhar jia children and young people with arthritis
Dr shridhar jia children and young people with arthritismilanb1
 
An understanding of the factors surrounding women’s and men’s h.docx
An understanding of the factors surrounding women’s and men’s h.docxAn understanding of the factors surrounding women’s and men’s h.docx
An understanding of the factors surrounding women’s and men’s h.docxgreg1eden90113
 
Setting Normative Function: Identification of areas where Standards and Guide...
Setting Normative Function: Identification of areas where Standards and Guide...Setting Normative Function: Identification of areas where Standards and Guide...
Setting Normative Function: Identification of areas where Standards and Guide...Human Variome Project
 
Integrating evidence based medicine and em rs
Integrating evidence based medicine and em rsIntegrating evidence based medicine and em rs
Integrating evidence based medicine and em rsTrimed Media Group
 

Similar to Med dra basic-training (20)

Who art & med dra
Who art & med draWho art & med dra
Who art & med dra
 
Who art & med dra
Who art & med draWho art & med dra
Who art & med dra
 
Statisticians Can\'t Analyze Text!
Statisticians Can\'t Analyze Text!Statisticians Can\'t Analyze Text!
Statisticians Can\'t Analyze Text!
 
01 conspectus of disease
01 conspectus of disease01 conspectus of disease
01 conspectus of disease
 
Information Genetic Content (IGC): a comprehensive discovery platform for dis...
Information Genetic Content (IGC): a comprehensive discovery platform for dis...Information Genetic Content (IGC): a comprehensive discovery platform for dis...
Information Genetic Content (IGC): a comprehensive discovery platform for dis...
 
Searching PubMed
Searching PubMedSearching PubMed
Searching PubMed
 
SNOMED CT and other healthcare terminology standards: competition or cooperat...
SNOMED CT and other healthcare terminology standards: competition or cooperat...SNOMED CT and other healthcare terminology standards: competition or cooperat...
SNOMED CT and other healthcare terminology standards: competition or cooperat...
 
The Translational Medicine
The Translational MedicineThe Translational Medicine
The Translational Medicine
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Toward Creating a gold Standard of Drug Indications from FDA Drug Labels
Toward Creating a gold Standard of Drug Indications from FDA Drug LabelsToward Creating a gold Standard of Drug Indications from FDA Drug Labels
Toward Creating a gold Standard of Drug Indications from FDA Drug Labels
 
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
Anne Wojcicki of 23andMe at FDA Public Meeting on LDTs, July 20, 2010
 
Dr shridhar jia children and young people with arthritis.ppt
Dr shridhar jia children and young people with arthritis.pptDr shridhar jia children and young people with arthritis.ppt
Dr shridhar jia children and young people with arthritis.ppt
 
Dr shridhar jia children and young people with arthritis.ppt 121011
Dr shridhar jia children and young people with arthritis.ppt 121011Dr shridhar jia children and young people with arthritis.ppt 121011
Dr shridhar jia children and young people with arthritis.ppt 121011
 
Dr shridhar jia children and young people with arthritis.ppt 121011
Dr shridhar jia children and young people with arthritis.ppt 121011Dr shridhar jia children and young people with arthritis.ppt 121011
Dr shridhar jia children and young people with arthritis.ppt 121011
 
Dr shridhar jia children and young people with arthritis
Dr shridhar jia children and young people with arthritisDr shridhar jia children and young people with arthritis
Dr shridhar jia children and young people with arthritis
 
An understanding of the factors surrounding women’s and men’s h.docx
An understanding of the factors surrounding women’s and men’s h.docxAn understanding of the factors surrounding women’s and men’s h.docx
An understanding of the factors surrounding women’s and men’s h.docx
 
Setting Normative Function: Identification of areas where Standards and Guide...
Setting Normative Function: Identification of areas where Standards and Guide...Setting Normative Function: Identification of areas where Standards and Guide...
Setting Normative Function: Identification of areas where Standards and Guide...
 
The State of Play in Diagnosis
The State of Play in DiagnosisThe State of Play in Diagnosis
The State of Play in Diagnosis
 
Integrating evidence based medicine and em rs
Integrating evidence based medicine and em rsIntegrating evidence based medicine and em rs
Integrating evidence based medicine and em rs
 
Gdt
GdtGdt
Gdt
 

Recently uploaded

Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 

Recently uploaded (20)

Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 

Med dra basic-training

  • 1. Introduction to MedDRA® and its use Kathryn Huntley Huntley Consulting, LLC DAIDS Contractor February 21, 2006 1
  • 2. MedDRA Med= Medical D = Dictionary for R = Regulatory A = Activities 2
  • 3. MedDRA Definition MedDRA is a clinically-validated international medical terminology used by regulatory authorities and the regulated biopharmaceutical industry. The terminology is used through the entire regulatory process, from pre-marketing to post-marketing and for data entry, retrieval, evaluation and presentation 3
  • 4. Scope OUT Drug product terms IN Diseases Population-level qualifiers Diagnoses Signs Symptoms Patient demographic Therapeutic indications Numerical values for terms Investigation names & qualitative results results Medical & surgical procedures Medical, social, family history Terms from: COSTART Device failure terms WHO-ART Severity descriptors HARTS Equipment, device, diagnostic product terms Clinical trial study design terms
  • 5. MedDRA Structure and Growth Version 2.1 Version 7.0 Version 8.0 26 26 26 System Organ Class 334 332 332 High-Level Group Term 1,663 1,681 1,683 High-Level Term 11,193 16,449 16,751 Preferred Term 35,065 44,755 45,597 Lowest-Level Term 5
  • 6. MedDRA Structure and Growth Version 8.0 Version 8.1 26 26 System Organ Class 332 332 High-Level Group Term 1,683 1,683 High-Level Term 16,751 16,976 Preferred Term 45,597 45,974 Lowest-Level Term 6
  • 7. System Organ Class Highest level of the hierarchy SOCs identified by Anatomical or physiological system Etiology Purpose 7
  • 8. System Organ Class Blood and lymphatic system Musculoskeletal and connective disorders tissue disorders Cardiac disorders Neoplasms benign, malignant and Congenital, familial and genetic unspecified (incl cysts and polyps) disorders Nervous system disorders Ear and labyrinth disorders Pregnancy, puerperium and Endocrine disorders perinatal conditions Eye disorders Psychiatric disorders Gastrointestinal disorders Renal and urinary disorders General disorders and Reproductive system and breast administration site conditions disorders Hepatobiliary disorders Respiratory, thoracic and Infections and infestations mediastinal disorders Immune system disorders Skin and subcutaneous tissue disorders Injury, poisoning and procedural Social circumstances complications Investigations Surgical and medical procedures Metabolism and nutrition disorders Vascular disorders 8
  • 9. High Level Group Term Subordinate only to System Organ Classes and superordinate descriptor for one or more HLTs SOC Gastrointestinal disorders HLGT HLGT HLGT Dental and Gastrointestinal Gastrointest gingival infections inal vascular conditions conditions
  • 10. High Level Term Subordinate to HLGTs and superordinate descriptors for the PTs linked to it SOC Gastrointestinal disorders HLGT Gastrointestinal infections HLT HLT Gastrointestinal HLT Intestinal infections, site Peritoneal infections infections unspecified
  • 11. Preferred Term Each Preferred Term represents a single medical concept: • SOC Gastrointestinal disorders – HLGT Gastrointestinal infections – HLT - Gastrointestinal infections, site unspecified - PTs Abdominal sepsis, Amoebic dysentery, Tuberculosis gastrointestinal, Gastrointestinal anthrax . . . 11
  • 12. Preferred Term PT Characteristics • No limit to the amount of LLTs that can be associated with a single PT • An identical LLT is created for every PT • Each path to a SOC from a PT should have exactly one HLT and HLGT (one route) PT → HLT → HLGT → SOC • PTs can be represented in multiple SOCs (multiaxality) 12
  • 13. Lowest Level Term LLT Characteristics: Developed to support consistent coding • An LLT has one or more of the following relationships to a PT: – Synonym – Lexical variant – Quasi-synonym (colloquial terms) • Many terms from included terminologies are represented at the LLT level 13
  • 14. Lowest Level Term LLT Characteristics cont. • Constitutes the entry level of the terminology and is linked to a single PT • Can have current or non-current status • Culturally unique terms are found at this level 14
  • 15. NEC = Not Elsewhere Classified For specific, yet miscellaneous, terms that do not readily fit into hierarchical classifications, used only at the HLT and HLGT levels HLT Congenital disorders NEC PT PT Hereditary Congenital PT PT PT angioedema abnormality Conjoined Hereditary Umbilical twins disorders malformation
  • 16. MedDRA Codes Each MedDRA term assigned an 8-digit numeric code The code is non-expressive Codes can fulfill a data field in various electronic submission types (e.g., E2b) Initially assigned alphabetically by term starting with 10000001 New terms are assigned sequentially Codes are never reused Supplemental terms are assigned codes 16
  • 17. Anatomy (Body System) Blood and lymphatic system disorders Cardiac disorders Ear and labyrinth disorders Endocrine disorders Eye disorders Gastrointestinal disorders Hepatobiliary disorders Immune system disorders Musculoskeletal and connective tissue disorders Nervous system disorders Psychiatric disorders Renal and urinary disorders Reproductive system and breast disorders Respiratory, thoracic and mediastinal disorders Skin and subcutaneous tissue disorders Vascular disorders 17
  • 18. Other (Cause/Association) Congenital, familial and genetic disorders General disorders and administration site conditions Infections and infestations Injury, poisoning and procedural complications Investigations Metabolism and nutrition disorders Neoplasms benign, malignant and unspecified (incl cysts and polyps) Pregnancy, puerperium and perinatal conditions Social circumstances Surgical and medical procedures 18
  • 19. General disorders and administration site conditions SOC specific topics: SOC includes terms that are very general in nature e.g.. Pain, Mass, Tenderness etc. Administration site conditions all grouped here (also in Injury SOC). • Application • Injection • Implant Much of this SOC is not multi-axial 19
  • 20. Congenital, familial and genetic disorders SOC specific topics: Primary SOC for all congenital conditions Primary SOC for all congenital conditions Congenital = any condition present at birth, whether genetically inherited or acquired in utero definition used for placement into this SOC HLGTs categorized either by an anatomical basis following the naming conventions of the SOCs Look here for the congenital condition, look in the anatomy SOC for grouping with non-congenital conditions 20
  • 21. Injury, poisoning and procedural complications SOC specific topics: Can be considered the “due to SOC” HLGTs are representing either the agent that caused the injury or anatomy Only SOC where cardiac and vascular are considered together (cardiovascular injuries) Overdose, poisoning, misadministrations etc are located here 21
  • 22. Investigations SOC specific topics: Single axial SOC Represents only the results of tests (no interpretation) HLGTs represent various large groupings of tests PTs naming convention is: Test identifier, specimen type, qualifier • Qualifiers include: normal, increased, decreased, abnormal NOS (no direction of abnormality specified) – There will always be an investigation term without any qualifier to be used when no value is given (e.g., PT: Hematocrit) 22
  • 23. Infections and infestations SOC specific topics: All infections are primary to the Infection SOC HLGTs categorized either infectious agent or on an anatomical basis under pathogen class unknown. HLGT refers to taxonomy of pathogen e.g.. Bacterial, Fungal etc. HLT references the genus PT refers to genus plus anatomy LLT references the species 23
  • 24. Metabolism and nutrition disorders SOC specific topics: HLGTs represent metabolic disorders divided by substance being metabolized or nutritional disorders This SOC is based upon substance, cause would be represented in anatomical or congenital SOCs 24
  • 25. Neoplasms benign, malignant and unspecified (incl cysts and polyps) SOC specific topics: Primary SOC for all Neoplasms Secondary SOC for all Cysts and Polyps Developed with the help of National Cancer Institute (CTEP) Applies international naming conventions HLGTs classify anatomy HLTs distinguish staging Includes very specific as well as very general terms 25
  • 26. Pregnancy, puerperium and perinatal conditions SOC specific topics: Contains terms for classifying disorders as well as normal conditions Age is important in using this SOC e.g.. Neonatal Topics of mother and child are covered within this SOC The HLGT Abortion and stillbirth includes spontaneous and abnormal conditions, procedures and complications 26
  • 27. Social circumstances SOC specific topics: Contains terms for categorizing life style factors Does not contain disorders Single axial Drug and chemical abuse does not include alcohol Coding with this SOC requires full understanding of the SOC and its interpretation 27
  • 28. Surgical and Medical Procedures SOC specific topics: HLGTs are broken down by anatomy or procedural type Only section of the terminology where Ear, nose and throat are grouped. Single axial Represents only procedures, complications are represented in the Injury, poisoning and procedural complications SOC, the reason for the procedure is represented in the disorders SOC 28
  • 29. In what SOC would you find the following: Hypoglycemia Decreased heart rate Drug addict Bacterial infection Pneumonitis Broken leg Injection site pain 29
  • 30. Using MedDRA’s Hierarchy Important functions of a hierarchy are as follows: Provides a grouping scheme for data analysis Defines the meaning of word and its relationship to terms associated with it Defines/limits the meaning of lateral terms Serves as a pre-developed method of grouping data for analysis Supports consistent data representation Supports standardized data reporting. MedDRA is NOT a taxonomy. Be careful to understand the interaction of the hierarchy and multiaxiality. 30
  • 31. A Multi-Axial Terminology Multi-axial = the representation of a medical concept in multiple SOCs Allows terms to be grouped by different classifications Allows retrieval and presentation via different data sets Allows an automatic assignment of pre-defined term groupings 31
  • 32. Primary SOC Allocation Every PT is assigned to a Primary SOC Purpose of Primary SOC – Determines which SOC will represent a PT during cumulative data outputs – Is used to support consistent data presentation for reporting – Secondary SOCs are used for additional scientific analysis 32
  • 33. Rules for Primary SOC Allocation PTs relating to diseases or signs and symptoms are assigned to the SOC that best represents the primary manifestation site PT: Appendicitis = Primary SOC: Gastrointestinal disorders PT: Dry Skin = Primary SOC: Skin & subcutaneous tissue disorders PT: Nausea = Primary SOC: Gastrointestinal disorders 33
  • 34. Exceptions for Primary SOC Allocation All congenital and hereditary anomalies are placed in the Congenital, familial and genetic disorders SOC as their Primary SOC 34
  • 35. Exceptions for Primary SOC Allocation Primary SOC Congenital and familial/genetic disorders Example PT Congenital rubella infection Secondary SOC Pregnancy, puerperium and perinatal conditions Infections and infestations 35
  • 36. Exceptions for Primary SOC Allocation All neoplasms are placed in the Neoplasms benign and malignant (including cysts and polyps) SOC as their Primary SOC 36
  • 37. Exceptions for Primary SOC Allocation Primary SOC Neoplasms benign,malignant and unspecified (including cysts and polyps) Example PT Benign lung neoplasm Secondary SOC Respiratory, thoracic and mediastinal disorders 37
  • 38. Exceptions for Primary SOC Allocation Exception: Cysts and polyps are placed in the prime manifestation site as their Primary SOC 38
  • 39. Exceptions for Primary SOC Allocation Primary SOC Ear and labyrinth disorders Example PT Secondary SOC Aural polyp Neoplasms benign, malignant and unspecified (including cysts and polyps) 39
  • 40. Exceptions for Primary SOC Allocation All infections and infestations are placed in the Infections and infestations SOC as their Primary SOC 40
  • 41. Exceptions for Primary SOC Allocation Primary SOC Infections and infestations Example PTs Secondary SOC Hepatitis C Hepato-biliary disorders Nervous system disorders Encephalitis Respiratory, thoracic and Pneumonia mediastinal disorders 41
  • 42. A Multiaxial Terminology PTs in the following SOCs only appear in that particular SOC: Investigations Social circumstances Surgical and medical procedures. 42
  • 43. Multiaxial Terminology SOC = Respiratory, thoracic and SOC = Infections and mediastinal disorders infestations HLGT = Upper respiratory HLGT = Viral infectious tract infections disorders HLT =Viral upper respiratory HLT = Influenza viral tract infections infections PT = Influenza 43
  • 44. A Multiaxial Terminology SOC = Endocrine SOC = Metabolism and disorders nutrition disorders HLGT = Glucose metabolism disorders (including diabetes mellitus) HLT = Diabetes mellitus (including subtypes) PT = Diabetes mellitus 44
  • 45. Using MedDRA to Your Benefit Multiaxiality SOC= Infection and SOC = Hepatobiliary infestations disorders HLGT = Viral HLGT = Hepatic disease disorders HLT = Hepatic viral infection PT = Hepatitis C 45
  • 46. Using MedDRA to Your Benefit Multiaxiality (Continued) SOC = Hepatobiliary disorders HLGT = Hepatic disorders HLT = Hepatic HLT = Hepatic signs viral infection and symptoms PT = Hepatitis C PT = Hepatomegaly 46
  • 47. Using MedDRA to Your Benefit Multiaxiality (Continued) Impact of multiaxiality on analysis: PTs are represented in more than one SOC. Secondary path is used in SOC analysis. Use of multiaxiality. Double counting is prevented. Multiple data representation is supported. Related terms in different SOCs are revealed. 47
  • 48. In what SOC would the following terms be primary: Community acquired pneumonia Congenital HIV infection Kaposi’s Sarcoma HIV wasting syndrome Wasting Intestinal polyp Endometrial sarcoma 48
  • 49. Special Search Category Standardizes frequently used searches Helps define the syndromes/diseases Facilitates analysis across SOCs Groups PTs at the PT level (horizontally) Will be retired with MedDRA version 10 49
  • 50. Special Search Categories Anaphylaxis (SSC) Arrest (Cardiac) (SSC) Blood dyscrasias/bone marrow depression (SSC) Cardiac ischaemia (SSC) Haemorrhage (SSC) Hypersensitivity reactions (SSC) Oedema (SSC) Pain (SSC) Premalignant lesions (SSC) Secondary immunocompromised state (SSC) Thrombosis (SSC) Upper GI bleeding/perforation (SSC) Vasculitis (SSC) 50
  • 51. Standardized MedDRA Query Standardizes frequently used searches Helps define the syndromes/diseases Facilitates analysis across SOCs Allows for broad and narrow searches (sensitivity vs. specificity) Is tested by MedDRA subscribers Is maintained by the MedDRA MSSO 51
  • 52. Acknowledgement MedDRA® is a registered trademark of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) 52